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Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin
Mediate Protection against Lethal Influenza Virus Infection
Deborah M. Brown, Sarah Lee, Maria de la Luz Garcia-Hernandez,* and Susan L. Swain*
School of Biological Sciences, Nebraska Center for Virology, University of Nebraska—Lincoln, Lincoln, Nebraska, USA

CD4 effectors generated in vitro can promote survival against a highly pathogenic influenza virus via an antibody-independent
mechanism involving class II-restricted, perforin-mediated cytotoxicity. However, it is not known whether CD4 cells activated
during influenza virus infection can acquire cytolytic activity that contributes to protection against lethal challenge. CD4 cells
isolated from the lungs of infected mice were able to confer protection against a lethal dose of H1N1 influenza virus A/Puerto
Rico 8/34 (PR8). Infection of BALB/c mice with PR8 induced a multifunctional CD4 population with proliferative capacity and
ability to secrete interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-␣) in the draining lymph node (DLN) and gamma
interferon (IFN-␥) and IL-10 in the lung. IFN-␥-deficient CD4 cells produced larger amounts of IL-17 and similar levels of
TNF-␣, IL-10, and IL-2 compared to wild-type (WT) CD4 cells. Both WT and IFN-␥ⴚ/ⴚ CD4 cells exhibit influenza virus-specific
cytotoxicity; however, IFN-␥-deficient CD4 cells did not promote recovery after lethal infection as effectively as WT CD4 cells.
PR8 infection induced a population of cytolytic CD4 effectors that resided in the lung but not the DLN. These cells expressed
granzyme B (GrB) and required perforin to lyse peptide-pulsed targets. Lethally infected mice given influenza virus-specific CD4
cells deficient in perforin showed greater weight loss and a slower time to recovery than mice given WT influenza virus-specific
CD4 cells. Taken together, these data strengthen the concept that CD4 T cell effectors are broadly multifunctional with direct
roles in promoting protection against lethal influenza virus infection.

I

nfluenza virus infection remains a serious global health problem, with over 30,000 deaths each year in the United States.
Immunocompromised individuals as well as the elderly and infants are at greater risk due to the lowered immune responses in
these populations. In addition, the appearance of pandemic
strains such as 2009 H1N1 underscores the need to develop new
strategies to counteract this pathogen. Current vaccines against
influenza virus rely on activating the humoral B cell response to
induce high-affinity neutralizing antibodies against the outer coat
proteins of the virus. However, these proteins undergo rapid mutation (antigenic drift) and can reassort in other animals such as
swine (antigenic shift) to create new strains that have pandemic
potential (38). While vaccine-induced neutralizing antibodies
provide sterilizing immunity against the immunizing strain, vaccines must be reformulated each year to include the most prevalent circulating influenza viruses. In contrast to immunity against
outer proteins, cellular immunity consisting of T cell responses is
mainly directed against internal proteins of the virus, such as nucleoprotein (NP) and acid polymerase (PA). These internal proteins have a much lower mutation rate and tend to be conserved
across many seasonal strains of influenza virus. Thus, it is important to understand the cellular immune response to influenza virus infection, to help in the design of more effective, universal
influenza vaccines that protect against emerging pandemic and
avian influenza virus strains.
Cellular immunity to influenza virus infection involves both
CD8 and CD4 T cell subsets. It is widely believed that CD8 cells
promote viral clearance via cytotoxic mechanisms, lysing virally
infected epithelial cells. This direct mode of protection has been
shown to utilize both perforin- and FasL-mediated cytotoxicity
(41). In contrast, CD4 T cells are known to provide indirect help in
viral clearance by secreting cytokines and inducing high-affinity
antibodies that neutralize virus and provide protection against
reinfection with the same strain (18, 23). CD4 T cells differentiate
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into T helper 1 (Th1) effectors in response to influenza virus infection and secrete large amounts of gamma interferon (IFN-␥) in
the lung (31). IFN-␥ expression is heterogeneous in T cells, and
cells with the highest expression migrate to the lung (20). This
cytokine is important for driving isotype switching to IgG2a and
IgG3, as mice treated with anti-IFN-␥ antibodies demonstrate
lower anti-influenza virus titers (3). However, studies using mice
deficient in IFN-␥ suggest that this cytokine is dispensable for
cytotoxic T lymphocyte (CTL) function and survival from lethal
infection (15). Graham et al. also demonstrated that a CD4 T cell
clone deficient in IFN-␥ could protect mice from lethal influenza
virus infection (15), and our own previous data confirmed that
␥⫺/⫺ CD4 effectors generated in vitro could protect from lethal
challenge (7). However, the contribution of IFN-␥ in the CD4
effector-mediated response to influenza virus infection and
whether in vivo-generated CD4 effectors could promote protection by IFN-␥-mediated or cytolytic mechanisms were not addressed in these studies.
More recently, a direct role for CD4 T cells has been suggested
in chronic infections, such as cytomegalovirus (CMV), EpsteinBarr virus, and HIV infections in humans (43) and gammaherpesvirus infections in mice (35). These data indicate that chronic
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antigen exposure induces a highly differentiated CD4 T cell effector with cytolytic potential (1). These effectors express perforin
and granzymes and undergo granule exocytosis upon antigen reexposure (9). Our previous work demonstrated that CD4 effectors
generated in vitro could acquire cytolytic activity (7, 8) and were
able to protect mice from a lethal dose of influenza virus using
perforin-mediated cytolytic mechanisms in synergy with B cell
help (7). However, it is not known whether CD4 cells activated
during an acute infection can become cytotoxic or whether this
activity helps control infection. In this study, we set out to determine the mechanisms used by CD4 T cells during an acute influenza viral infection, whether CD4 effectors generated in vivo could
acquire cytolytic activity, and which mechanisms contributed to
protection from a lethal dose of influenza virus. We found that
CD4 cells have different effector profiles in the draining lymph
node (DLN) than the lung and that CD4 cells secrete IFN-␥ at the
site of infection that can contribute to protection. In addition,
CD4 cells acquire perforin-mediated cytotoxicity in the lung, but
not the DLN, that may enhance recovery from lethal infection.
MATERIALS AND METHODS
Mice. BALB/c By mice were purchased from the Jackson Laboratory, Bar
Harbor, ME. IFN-␥⫺/⫺ mice on the BALB/c background (45) and BALB/c
Thy1.1 mice, originally obtained from Jonathan Sprent (The Scripps Research Institute, La Jolla, CA) were maintained at the Trudeau Institute
Animal Breeding Facility. T cell receptor (TCR) transgenic (Tg) mice in
which CD4 cells recognize the hemagglutinin peptide from residues 126
to 138 (HA126-138) from H1N1 influenza virus A/Puerto Rico 8/34 (PR8)
were a gift from D. Lo (The Scripps Research Institute, La Jolla, CA) and
have been described in detail (32). HA-specific TCR Tg mice, which we
refer to as HNT mice (because the amino acid sequence of the peptide
recognized by these cells begins with HNT), were bred to IFN-␥⫺/⫺ and
BALB/c Thy1.1 mice at the Trudeau Institute Animal Breeding Facility to
generate HNT IFN-␥⫺/⫺ mice and HNT Thy1.1 mice, respectively. Perforin-deficient (Pfn⫺/⫺) mice on the BALB/c background were a gift from
J. Harty (University of Iowa, Iowa City, IA) and were bred to HNT mice at
the Trudeau Institute Animal Breeding Facility (7). B cell-deficient mice
homozygous for a disruption at the JH locus (JHD) (30) backcrossed to
BALB/c mice were also maintained at the Trudeau Institute Animal
Breeding Facility. All experimental animal procedures were conducted in
accordance with the Trudeau Institute Animal Care and Use Committee
guidelines.
Influenza virus and infections. PR8 was grown in the allantoic cavity
of embryonated hen’s eggs as previously described (28). BALB/c or
BALB/c IFN-␥⫺/⫺ mice were infected intranasally with 500 egg infectious
units (EIU) PR8 in 50 l of phosphate-buffered saline (PBS) as a sublethal
dose for analysis of CD4 effector functions or 5,000 to 10,000 EIU as a
lethal dose for survival experiments.
Isolation of cell populations, adoptive transfer, and lethal infection.
Influenza virus-infected BALB/c mice were sacrificed at various times
postinfection (p.i.) with a lethal dose of tribromoethanol (Avertin) anesthesia intraperitoneally. Lungs were perfused via the right ventricle of the
heart with PBS, minced, and incubated with collagenase D at a 2.5-mg/ml
final concentration to dissociate lung tissue. Single-cell suspensions were
filtered through 70-m-mesh-size mesh and used in various assays or
further incubated with anti-CD4-conjugated magnetic beads (clone
GK1.5) according to the manufacturer’s protocol (Miltenyi Biotec). We
typically observed a ⬎80% enrichment in CD4⫹ T cell effectors from the
lung, with each mouse yielding approximately 2 ⫻ 106 to 4 ⫻ 106 CD4
cells. DLN cells were dissociated, and single-cell suspensions were used in
various assays or further enriched with anti-CD4 magnetic beads as described above. Total CD4 cells (1 ⫻ 107) were injected into naïve host mice
and 18 h later infected with 5,000 to 10,000 EIU PR8 in 50 l PBS intranasally (i.n.). Mice were then monitored for weight loss and survival over
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the course of the experiment. Mice were euthanized when they became
moribund, according to the Trudeau Institute Animal Care and Use
Committee guidelines. Kaplan-Meier survival curves were generated, and
statistical significance was analyzed by the log-rank test.
Isolation of TCR Tg CD4 cells and adoptive transfer. Naïve CD4 cells
were isolated from TCR Tg mice using a positive-selection protocol with
anti-CD4 beads (clone GK1.5) according to the manufacturer’s protocol
(Miltenyi Biotec, Cambridge, MA). Naïve HNT or HNT ␥⫺/⫺ CD4 cells
(1 ⫻ 106 to 2 ⫻ 106) were injected via the tail vein into BALB/c and
BALB/c IFN-␥⫺/⫺ mice, respectively. In some experiments, wild-type
(WT) HNT or HNT Pfn⫺/⫺ CD4 cells were injected into naïve host mice
via the tail vein. At 18 to 24 h after adoptive transfer, mice were infected
i.n. with 500 EIU PR8. At 7 to 10 days postinfection, mice were sacrificed
and CD4 cells were isolated from DLN and lung as described above. This
population included TCR Tg CD4 cells as well as endogenous CD4 T cell
effectors and was used for in vitro assays or survival studies where noted in
the figure legends. Typically, 2 to 5% of the CD4 cells isolated from the
DLN were HNT specific, while a range of from 6 to 12% of the CD4 cells
in the lung were HNT specific.
Medium and peptides. All cells were grown in RPMI 1640 containing
2 mM L-glutamine, 100 IU penicillin, and 100 g/ml streptomycin (all
obtained from Invitrogen Life Technologies), 10 mM HEPES (Research
Organics), 50 M 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO),
and 8% fetal bovine serum (FBS) (HyClone). HA peptide from residues
126 to 138 (HA126-138; HNTNGVTAACSHE), HA peptide from residues
518 to 526 (HA518-526; IYSTVAASL), NP peptide from residues 146 to 160
(NP146-160; ATYQRTRALVRTGMD), and NP peptide from residues 216
to 230 (NP216-230; RIAYERMCNILKGKF) were synthesized by New England Peptide (Gardner, MA).
Proliferation assay. DLNs were harvested from influenza virus-infected
mice at 7 to 10 days postinfection, dissociated to a single-cell suspension, and
incubated with irradiated H-2d-expressing A20 B lymphoma cells as antigenpresenting cells (APCs) and specific influenza virus peptides at 37°C for 48 h.
[3H]thymidine (Amersham Biosciences, Piscataway, NJ) at 0.2 Ci/well was
added for 18 h, plates were harvested using a Filtermate harvester (Perkin
Elmer, Shelton, CT), and incorporated 3H was measured using a Microbeta
Trilux scintillation counter (Perkin Elmer). Results are expressed as a stimulation index, calculated by dividing the number of counts per minute obtained in wells stimulated with peptide or anti-CD3 by the number of counts
per minute in medium control wells.
Enzyme-linked immunosorbent spot (ELISpot) assay for cytokinesecreting cells. Multiscreen HA plates (Millipore) were coated overnight
with anti-IFN-␥ antibody (clone R4-6A2; BD Biosciences) or anti-IL-17
antibody (R&D Systems, Minneapolis, MN) at 5 g/ml in PBS. Plates
were washed with PBS–Tween 20 and blocked using complete RPMI 1640
medium with 10% FBS. DLN or lung cells were added at 106 cells/well and
serially diluted 1:2 in RPMI medium. Irradiated naïve splenocytes were
added as APCs with or without major histocompatibility complex class
II-restricted PR8 HA126-138, HA110-120, NP147-160, and NP216-230. Plates
were incubated overnight at 37°C, washed with PBS–Tween 20, and incubated with biotinylated anti-IFN-␥ antibody (clone XMG1.2; BD Biosciences) or biotinylated anti-IL-17 antibody (R&D Systems) at 1 g/ml
overnight at 4°C. Plates were washed with PBS–Tween 20 and incubated
with streptavidin-alkaline phosphatase (ExtraAvidin; Sigma-Aldrich) at
1:500 for 1 h at 25°C. Spots were developed using a 1-mg/ml solution of
5-bromo-4-chloro-3-indolyl phosphate–nitroblue tetrazolium (BCIP/
NBT; Sigma-Aldrich). Spots were counted using an Immunospot counting system (Cellular Technologies, Ltd.). Data are plotted as the number
of IFN-␥ spots per input cell number.
Immunofluorescence. Frozen lung sections (5 m) from PR8-infected and uninfected mice were blocked with PBS containing Fc Block
(10 g/ml) and 5% donkey serum (Jackson ImmunoResearch Laboratories, West Grove, PA) for 30 min at room temperature. To block endogenous biotin, lung sections were incubated with 100 l of avidin (1 mg/
ml) for 15 min at room temperature (RT), followed by 100 l of biotin (1
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FIG 1 CD4 effectors from the DLN and lung provide protection from lethal-dose influenza virus infection. Healthy BALB/c mice were infected with 500 EIU PR8
i.n., and 7 to 10 days later, CD4 cells were isolated from the DLN or lung using anti-CD4-conjugated magnetic beads. CD4 cells from the DLN (A), lung (B), or
DLN and lung combined (C) were adoptively transferred intravenously to naïve BALB/c mice that were subsequently infected with 5,000 EIU PR8, and survival
was monitored over time. Kaplan-Meier curves were generated by Prism software. In all graphs, survival of mice given CD4 cells is significantly higher than that
in mice left untreated (none) by the log-rank test (P ⱕ 0.01).

mg/ml) for 15 min at RT (Sigma). Lung sections were then incubated with
biotin-conjugated anti-mouse I-Ad and fluorescein isothiocyanate
(FITC) anti-mouse Thy1.1 (BD biosciences) for 30 min at RT. As a control, lung sections were incubated with an irrelevant isotype control
(biotin-conjugated IGg2a,k; BD Biosciences). Class II was detected with
streptavidin conjugated to Alexa Fluor 594 and T cells with anti-FITC
conjugated to Alexa Fluor 488 (Molecular Probes, Carlsbad, CA). Type II
alveolar epithelial cells were detected using rabbit polyclonal anti-prosurfactant protein C (Abcam, Cambridge, MA) (data not shown). Bound
antibodies were detected with donkey anti-rabbit antibody conjugated to
Texas Red (Jackson ImmunoResearch). Sections were mounted with medium for fluorescence with 4=,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA).
ICCS. CD4 T cells were isolated from DLN, spleen, or lung and restimulated for 4 h with 10 ng/ml phorbol myristate acetate (PMA) and 500
ng/ml ionomycin (Sigma-Aldrich) or for 6 h with peptide-pulsed A20
cells as APCs. Brefeldin A (10 g/ml; Sigma-Aldrich) was added for the
final 2 h of culture and maintained throughout the intracellular cytokine
staining (ICCS) procedure. In some experiments, donor T cells were surface stained with anti-Thy1.1 or anti-Thy1.2 and anti-CD4 as described
previously (7, 16), fixed in 100 l 4% paraformaldehyde, and stained in
saponin buffer (PBS plus 1% FBS, 0.1% NaN3, and 0.25% saponin; Sigma-Aldrich) containing anti-IFN-␥–APC, anti-IL-17–phycoerythrin
(PE), anti-IL-2–FITC or anti-tumor necrosis factor alpha (anti-TNF␣)–PE (all antibodies were purchased from BD Biosciences). In some
experiments, APC-conjugated mouse anti-human granzyme B (GrB;
clone GB12; Caltag, Burlingame, CA) was used to measure intracellular
levels of GrB protein in infected samples. APC-conjugated mouse IgG1
was used as an isotype control (Caltag).
Reverse transcription-PCR for transcription factors and cytolytic
markers. Mice were infected i.n. with 500 EIU PR8. Six to 8 days later,
mice were sacrificed and CD4 cells were isolated from the lung and DLN
by anti-CD4-conjugated magnetic beads. The flowthrough, enriched in
CD8⫹ cells, served as a positive control. Cells were resuspended in TRIzol
and RNA extracted with a RiboPure kit from Ambion (Applied Biosystems, Carlsbad, CA). cDNA was reverse transcribed with a high-capacity
cDNA reverse transcription kit (Applied Biosystems) according to the
manufacturer’s instructions and amplified using the following validated
TaqMan primer/probe sets: for Eomesodermin (Eomes), Mm01351985;
for T cell-specific transcription factor (T-bet), Mm00450960; for GrA,
Mm00439191; for GrB, Mm00442834; and for Pfn, Mm 00812512 (Applied Biosystems). Mouse GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as an endogenous control for amplification. Amplification was carried out using a Step-One Plus real-time PCR machine
from Applied Biosystems, and relative quantity was calculated by the delta
delta threshold cycle method using Applied Biosystems software.
JAM assay for cytotoxicity. Cytotoxicity was measured by the JAM
(Just Another Method) assay (19) as described previously (8). CD4 cells
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were isolated from DLN or lung as described above and plated at decreasing concentrations in 96-well round-bottom plates. A20 cells, labeled for
4 h with 4 Ci/ml [3H]thymidine (Amersham Biosciences), were added to
effectors at a concentration of 1 ⫻ 104 cells/well. HA126-138 was added at a
final concentration of 2 g/ml. In some experiments, a mixture of HA and
NP peptides was added at a concentration of 2 g/ml. Labeled A20 cells
without peptide served as a negative control. After 4 h at 37°C, plates were
harvested and incorporated [3H]thymidine was measured using a Microbeta Trilux scintillation counter (Perkin Elmer). In some experiments,
anti-FasL (clone MFL3) was added at 5 to 10 g/ml to inhibit Fas-mediated killing (8). Percent specific lysis was calculated as [(spontaneous
counts per minute ⫺ experimental counts per minute)/spontaneous
counts per minute] ⫻ 100 (19).
Statistical analyses. Statistical analyses were performed using Prism
software. The log-rank test was used for survival curves, and Student’s
two-tailed unpaired t test was used for analysis of statistical significance
between experimental samples.

RESULTS

CD4 effectors from the DLN and lung provide protection from
lethal influenza virus infection. Our previous results have demonstrated that Th1-polarized, in vitro-generated CD4 T cell effectors provide protection against a lethal dose of highly pathogenic
H1N1 virus, PR8 (7). We next wanted to determine if CD4 cells
generated in vivo in response to sublethal PR8 infection could
confer protection to naïve mice given a lethal challenge. Figure 1A
demonstrates that total CD4 cells isolated from the DLNs of
healthy BALB/c mice 7 days after sublethal infection could confer
protection against a lethal dose of PR8 when transferred to naïve
BALB/c mice. Similarly, CD4 cells isolated from the lung could
also confer protection against lethal challenge, but typically, not
all mice were protected from lethal challenge (Fig. 1B). Protection
was also observed when CD4 cells were isolated from the DLN and
lung and mixed prior to transfer and subsequent lethal infection
(Fig. 1C). Thus, terminally differentiated CD4 effectors in the lung
and activated CD4 cells in the DLN contribute to protection mediated by CD4 helper T cells.
CD4 cells display different functional properties in the DLN
than the lung. We next wanted to investigate the level of activation and possible effector functions used by CD4 T cells that may
be responsible for protection. To investigate this, we first analyzed the polyclonal response against endogenous influenza
virus CD4 epitopes using BALB/c mice infected with 500 EIU
PR8 and sacrificed at various times postinfection (Fig. 2A). Cell
suspensions from the DLN and lung were assayed for the ability
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FIG 2 CD4 cells display different functional properties in the DLN than the lung. (A) BALB/c mice were infected with 500 EIU, and DLN and lung cells were

isolated at various times postinfection to analyze the endogenous response. (B) Number of cells secreting IFN-␥ per 1 ⫻ 105 total input cells incubated with class
II-restricted peptides HA126-138 and NP216-230. Cells were also incubated with the class I-restricted NP147-160 as a positive control. (C) At day 7 postinfection, DLN
and lung cells were isolated and incubated with HA126-138-pulsed A20 cells, influenza virus-infected A20 cells, or anti-CD3 for 3 days, with [3H]thymidine added
for the last 18 h. Shown is the average fold expansion over that for the medium control for three separate experiments. (D) DLN and lung cell preparations isolated
at day 8 were incubated with antibodies to CD4, CD8, and GrB and subjected to flow cytometric analysis. A representative histogram of GrB expression gated on
CD4 or CD8 cell populations is shown. (E) Total CD4 or CD8 T cell numbers (left axis) in the lungs of influenza virus-infected mice were calculated by
multiplying total cell numbers by percent CD4- or CD8-positive cells analyzed by flow cytometry and the mean fluorescence intensity (MFI; right axis) of GrB
expression in individual mice. *, P ⫽ 0.0001 by unpaired Student’s t test. (F) HNT Thy1.1 CD4 cells (1 ⫻ 106 to 2 ⫻ 106) were adoptively transferred into healthy
BALB/c mice, and the mice were subsequently infected with 500 EIU PR8. At 7 days postinfection, DLN, spleen, and lung cell populations were isolated as
described in Materials and Methods and incubated with antibodies to CD4 and Thy1.1 to identify HNT peptide-specific CD4 cells. (G) Percentage of HNT cells
in each organ at day 7 p.i. from a representative experiment. (H) Average percentage ⫾ SD of CD4 Thy1.1 cells over time. (I) CD4 Thy1.1⫹ cells gated in panel
G were analyzed for expression of GrB directly ex vivo. The gate depicts cells that are positive for expression based on the isotype control. (J) DLN, spleen, and
lung cells isolated as in panel F were further restimulated with HA126-138 for 4 h in vitro and analyzed for the ability to produce IL-2 and IFN-␥ by flow cytometry.
Histograms show cells that were gated on CD4 and Thy1.1, as in panel G. The gate depicts cells that are positive for cytokine expression based on staining in the
medium controls. Samples were run on a BD FACScaliber apparatus, and data were analyzed using Flow Jo software. (K) Average percentage ⫾ SD of
cytokine-secreting cells (left axis) or GrB MFI (right axis) of CD4/Thy1.1⫹ cells in various organs at 7 days postinfection in three separate experiments.
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to secrete cytokines (Fig. 2B) and proliferate (Fig. 2C) upon
peptide restimulation. To determine the extent of cytokine secretion, DLN and lung single-cell suspensions were incubated
with a mixture of CD4-specific HA and NP peptides or the class
I binding CD8-specific NP147-159 as a positive control. CD4
IFN-␥ responses in the DLN peak early, at day 7, and decline
thereafter, while the frequency of CD4 cells able to secrete
IFN-␥ in the lung peaks at day 10. The frequency of CD8 cells
responding to NP peptide is approximately 2- to 3-fold higher
than the frequency of CD4 cells responding to HA and NP
peptides at all time points tested, with CD8 cells also peaking at
day 10 postinfection. This indicates that CD4 T cells produce a
substantial Th1-type response but that the response is lower in
magnitude than the CD8 T cell response, similar to our previous work using TCR Tg CD4 and CD8 populations (28). At 7
days postinfection, DLN cells proliferated in response to restimulation, while cells from the lung did not divide. CD4 cells
proliferated in response to HA126-138 2-fold over medium controls, and the response to influenza virus-infected APCs was
higher at approximately 4-fold (Fig. 2C).
Our previously published data showed that Th1-polarized, in
vitro-generated CD4 effectors expressed the serine protease GrB
and acquired perforin-mediated cytolytic activity (7, 8). To determine if CD4 T cell effectors generated in vivo also had this activity,
DLN and lung cells were stained with anti-CD4, anti-CD8, and
anti-GrB antibodies. Figure 2D demonstrates that CD4 cells residing in the lung 8 days after influenza virus infection express GrB,
but only approximately 0.4% of the cells in the DLN express this
protein. A higher proportion of CD8 T cells in the DLN (⬇6%)
express GrB, and all of the CD8 cells in the lung express GrB at
high levels. Indeed, the mean fluorescence intensity (MFI) of GrB
expression in CD8 cells is 5-fold higher than the MFI of GrB expression in CD4 cells (Fig. 2E). Thus, CD4 T cells can proliferate
and secrete IFN-␥ upon restimulation and express high levels of
GrB directly ex vivo after influenza virus infection. Although CD8
T cell responses are higher in magnitude in the lung, expression of
GrB by CD4 cells suggests that they may have a direct role in viral
clearance and protection.
To further analyze the CD4 response to influenza virus infection, we employed a TCR Tg mouse model in which all CD4 cells
recognize the HA126-138 in the context of class II I-Ad, termed HNT
mice. Approximately 1 ⫻ 106 HNT CD4 cells were adoptively
transferred into healthy BALB/c mice that were then infected with
a sublethal dose of PR8 (Fig. 2F). At 4, 7, and 11 days postinfection, single-cell suspensions from various organs were isolated
and the percentage of CD4 Thy1.1 cells was analyzed by flow cytometry. Figure 2G shows representative histograms of HNT-specific cells, with frequencies of 2.3% in the DLN, 0.3% in the spleen,
and 11.1% in the lung at day 7 p.i. The average percentage of
HNT-specific cells in the DLN, lung, and spleen over time is
shown in Fig. 2H, and the results confirm that peak CD4 T cell
responses in the adoptive transfer model occur at approximately
day 7 (28, 31). Gating on CD4 Thy1.1-positive (Thy1.1⫹) or
HA126-138-specific cells demonstrates that cells isolated from the
lung are more activated, indicated by high levels of the activation
isoform of CD43 (data not shown) and expression of GrB (Fig.
2I). In contrast, HNT-specific cells from the DLN and spleen do
not express GrB. To analyze cytokine secretion, CD4 cells were
isolated at day 7 postinfection and assayed for the ability to produce IL-2 or IFN-␥ in response to HA126-138. Figure 2J shows
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FIG 3 Lethal influenza virus infection induces class II expression on lung
epithelial cells. Mice were given HNT Thy1.1⫹ effectors and subsequently
infected with 5,000 EIU PR8. Five days later, mice were sacrificed and lungs
were frozen as described in Materials and Methods. Shown is immunofluorescent analysis of frozen lung sections from uninfected mice (B), mice infected
with 5,000 EIU PR8 (A and C), or infected mice given HNT Thy1.1⫹ CD4 cells
(D) incubated with antibodies against class II (red) or Thy1.1 (green). (D)
Staining of HNT-specific CD4 cells (green) in proximity to epithelial cells
expressing class II (red). Magnification, ⫻200.

representative histograms, while Fig. 2K quantifies the percentage
of positive cytokine-expressing cells in each organ. Restimulation
of the CD4⫹ fractions with HNT mouse peptide and subsequent
gating on CD4 Thy1.1 populations demonstrate that almost half
of all influenza virus-specific cells express IL-2 in the lymphoid
organs but only about 20% of cells express IFN-␥. Conversely,
almost 80% of HNT-positive cells in the lung express IFN-␥, but
only about 10% of cells express IL-2 (Fig. 2J and K). In addition,
high expression of GrB ex vivo correlates with IFN-␥ expression
after restimulation (Fig. 2K, left and right axes). Thus, in the infected site, Th1-polarized CD4 T cells develop, as do effectors that
express high levels of GrB. In contrast, cells expressing high levels
of GrB and IFN-␥ are rare in the DLN.
Lethal influenza virus infection induces class II expression
on epithelial cells, providing targets for cytolytic CD4 cells residing in the lungs. Because CD4 T cells could differentiate to
effector cells with cytolytic activity, we wanted to determine
whether the infected lung could provide potential class II-expressing targets for killing. In this experiment, we adoptively transferred in vitro-generated CD4 effectors that acquired perforinmediated cytolytic activity (7) and analyzed class II expression in
the lung 5 days after lethal infection. Figure 3B shows that epithelial cells in uninfected lungs do not express class II and class II
staining is restricted to cells in the parenchyma, probably macrophages. In contrast, lethal infection induces the expression of class
II on epithelial cells in the airways (Fig. 3C). This correlates with
cytokeratin expression in the same cells (data not shown). Importantly, in vitro-generated CD4 T cell effectors can be seen in close
proximity to the airways in the peribronchial areas of the lung
(Fig. 3D). Since in vitro-generated cytolytic CD4 cells protect mice
against lethal influenza virus infection in a perforin-dependent
manner and lethal infection upregulates class II on epithelial cells,
we next set out to determine whether CD4 T cells generated during sublethal influenza virus infection were cytolytic in vivo.
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FIG 4 Lung resident CD4 cells express granzymes and perforin and lyse peptide-pulsed targets. (A and B) Mice were infected with 500 EIU, and at 8 days
postinfection, CD4 cells were isolated from the DLN or lung as described in the text. The non-CD4 cells were used as a control that contained CD8 T cells. Shown
is the relative quantity of T-bet and Eomes (A) or GrA, GrB, and perforin (B) mRNA by real-time PCR using CD4 cells from the DLN as the reference sample.
Lung CD4 cells express significantly higher levels of T-bet than Eomes (P ⫽ 0.006 by Student’s unpaired t test). Shown is an average from three separate cell
isolations. (C) Mice were infected and cells were isolated as described for panels A and B and assayed for cytotoxicity against A20 cells pulsed with influenza
virus-specific class I peptides (NP147-156 and HA518-526) or class II peptides (HA126-138, NP216-230, and NP146-160) (left) or A20 cells pulsed with class II peptides
or infected with influenza virus (right). This experiment was repeated, with similar results. HNT Thy1.1 cells (1 ⫻ 106) were adoptively transferred to BALB/c
mice that were then infected with 500 EIU PR8. E:T, effector-to-target cell ratio. (D and E) Total CD4 cells were isolated by magnetic beads which contain
endogenous and TCR Tg CD4 cells (D) or Thy1.1⫹ cells, isolated by FACS, which are purified TCR Tg cells (E), from the DLN, spleen (Spl), and lung and
incubated with HNT-pulsed A20 target cells in a 4-h cytotoxicity assay. Shown is the percent lysis of each population against peptide-pulsed (closed symbols) or
unpulsed (open symbols) target cells. These experiments were repeated once (E) or twice (D) with similar results.

We first analyzed the cytolytic capacity of CD4 cells in the lung
by evaluating the expression of mRNA for proteins known to be
important for CD8 CTL differentiation (26, 27). Because CD4
cells in the DLN did not express GrB protein (Fig. 2D), these cells
were used as a reference sample in the quantitative PCR assays,
while CD8-enriched populations were used as positive controls.
Figure 4A demonstrates that CD4 cells isolated from the lung 8
days after sublethal infection upregulate the canonical Th1 transcription factor, T-bet. However, the level of Eomes expression is
lower in lung resident CD4 cells but higher in lung resident CD8
cells than the levels expressed in CD4 cells in the DLN. CD4 cells
in the lung show significantly higher expression of T-bet
mRNA than Eomes mRNA, suggesting that protein levels may
also be different. Figure 4B also indicates that lung resident CD4
cells show transcriptional upregulation of GrA, GrB, and Pfn
compared to CD4 cells isolated from the DLN. CD4 cells express
less Pfn and GrB mRNA than CD8 cells, and this correlates with
the expression of GrB protein observed in Fig. 2E. Thus, CD4 cells
residing in the lung have acquired the capacity to kill, as measured
by upregulation of mRNA for proteins contained in cytolytic
granules. We next wanted to determine if CD4 cells could lyse class
II-restricted peptide-coated targets and analyzed both the endogenous polyclonal response (Fig. 4C) and the HNT-specific response after transfer of TCR Tg CD4 cells (Fig. 4D and E). Figure
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4C demonstrates that CD4 cells isolated from the lung can lyse
A20 targets pulsed with a mixture of HA126-138 and NP216-230, although less effectively than CD8 cells against targets pulsed with
HA518-526 and NP147-160. In a separate experiment, total CD4 cells
isolated from the lung lysed peptide-pulsed as well as A20 targets
infected with PR8. Although cytolytic activity could be measured
in the polyclonal endogenous population of CD4 cells, we reasoned that killing activity in HNT-specific CD4 cells would be
easier to detect and used the same adoptive transfer method outlined in Fig. 2F to analyze CTL activity in HNT-specific cells. Isolation of total CD4 cells from the DLN, spleen, and lung at 7 days
after influenza virus infection demonstrates that CD4 cells in the
lung lyse HNT peptide-coated targets, while CD4 cells from the
DLN and spleen lack this activity (Fig. 4D). In this experiment, the
frequency of HNT-specific cells in the DLN was approximately
3%, while the frequency of HNT cells in the lung was closer to
12%. Thus, there could be cytolytic activity in the DLN, but since
the frequency of cells is low, we may not be able to detect this
activity in the CTL assay. To circumvent this problem, Thy1.1⫹
HNT-specific CD4 cells were sorted from either DLN or lung by
fluorescence-activated cell sorting (FACS) and used at the same
cell number in the CTL assay. Figure 4E confirms that cells in the
lung are highly cytolytic but cells in the DLN lack this activity.
Taken together, these data indicate that CD4 effectors have cyto-
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FIG 5 IFN-␥ is not required for the multifunctional CD4 T cell response to influenza virus infection. (A) BALB/c (WT) or BALB/c mice deficient in IFN-␥ (␥⫺/⫺)
were infected with 500 EIU and their weights were monitored over time. (B) Mice were bled at the indicated time points and analyzed for total influenza
virus-specific IgG (left) or influenza virus-specific IgG1 or IgG2a (right) at day 25 p.i. by enzyme-linked immunosorbent assay. Shown is the endpoint titer. P
values were determined by Student’s t test: *, P ⫽ 0.028; †, P ⫽ 0.002. (C) Cells from the DLN of WT and IFN-␥⫺/⫺ mice were restimulated in vitro with various
influenza virus-specific peptides for 72 h, and [3H]thymidine incorporation was measured as an indication of proliferation. Shown is the stimulation index
calculated as the fold increase over cells incubated in medium alone of three separate experiments. (D) CD4 cells were isolated from the lungs of WT (closed
symbols) or IFN-␥⫺/⫺ (open symbols) influenza virus-infected mice at various time points and incubated with HA or NP peptides in an ELISpot assay for IFN-␥
(closed symbols) or IL-17 (open symbols). Shown is the number of cytokine-secreting spots calculated for 1 ⫻ 106 CD4⫹ cells. (E) CD4 cells were isolated from
the lungs of WT (closed symbols) or IFN-␥⫺/⫺ (open symbols) influenza virus-infected mice at various time points and incubated with PMA and ionomycin. The
percentage of cytokine-positive cells after gating on activated (CD4⫹/CD43⫹) cells is shown over time for one representative experiment. (F) Shown is the
average ⫾ SD of percent cytokine-positive cells in WT and IFN-␥⫺/⫺ CD4 cells restimulated with PMA and ionomycin at day 10 p.i. from three separate
experiments. *, statistically significant difference in percent cytokine-positive cells between WT and IFN-␥⫺/⫺ cells (P ⬍ 0.005).

lytic activity in the lung but not in the DLN. Furthermore, influenza virus infection induces class II expression on epithelial cells
that can potentially serve as a target for cytolytic CD4 cells in the
lung.
IFN-␥ is not required for the multifunctional CD4 T cell response to influenza virus infection. Because the anti-influenza
virus CD4 response is predominantly Th1 mediated, with high
levels of IFN-␥ being secreted at the site of infection, we wanted to
determine the role of this cytokine during the generation of CD4
effectors. First, we wanted to examine whether an absence of
IFN-␥ had any effect on morbidity, as measured by weight loss
after sublethal infection. Figure 5A demonstrates that BALB/c WT
or IFN-␥⫺/⫺ mice display similar weight loss curves, suggesting
that the course of infection is similar between the two groups of
mice. Second, we also wanted to determine whether the helper
function of CD4 cells was intact in these mice and looked at antiinfluenza virus total IgG antibody titers as well as the titers of the
IgG1 and IgG2a subtypes. Figure 5B shows that anti-influenza
virus antibody titers are similar between WT and IFN-␥⫺/⫺ mice
over time but that WT mice produce significantly higher levels of
anti-influenza virus IgG2a, while IFN-␥⫺/⫺ mice express more
anti-influenza virus IgG1. In addition, the proliferative responses
of CD4 T cells in the DLN were comparable between WT and
IFN-␥⫺/⫺ mice (Fig. 5C), suggesting that the frequency of CD4
cells responding to influenza virus is similar between WT and
IFN-␥⫺/⫺ mice. We then isolated CD4 cells from the lungs of both
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WT and IFN-␥⫺/⫺ mice and investigated the ability of these cells
to secrete cytokines by ELISpot assay (Fig. 5D) and ICCS (Fig. 5E).
We measured the ability of IFN-␥⫺/⫺ cells to produce IL-17 since
CD4 cells have been shown to produce IL-17 in the absence of
IFN-␥ (11, 13). CD4 cells from WT mice produce IFN-␥ in response to HA and NP peptides with a frequency of approximately
1 in 100 at the peak of the response for the dominant HA and NP
peptides (Fig. 5D, closed symbols). IFN-␥⫺/⫺ CD4 cells produce
IL-17 in response to specific peptides, although the response to the
dominant HA and NP peptides is approximately 10-fold lower
(Fig. 5D, open symbols). CD4 responses in both WT and IFN␥⫺/⫺ mice peak at day 10 postinfection. In addition, cytokine
responses to PMA and ionomycin show that over half of WT CD4
cells in the lung can produce IFN-␥ and/or IL-10 (Fig. 5E and F,
closed symbols). Similar frequencies of lung CD4 cells from IFN␥⫺/⫺ mice produce IL-10, but only about 30% of cells produce
IL-17 (Fig, 5E and F, open symbols). CD4 cells from WT and
IFN-␥⫺/⫺ mice produce TNF-␣ and IL-2 in response to sublethal
influenza virus infection at about the same frequency (data not
shown). In addition, data obtained using multiplex cytokine assays reveal that CD4 cells from IFN-␥⫺/⫺ mice produce more
Th2-type cytokines than WT in response to influenza virus infection (data not shown). Therefore, CD4 effector functions are not
severely impacted in the absence of IFN-␥, and CD4 cells deficient
in IFN-␥ produce more IL-17, perhaps as a compensatory mechanism.
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FIG 6 IFN-␥ is dispensable for CTL activity but is necessary for complete protection from weight loss. (A) Schematic of endogenous CD4 effector generation for

analysis of CTL activity. WT or IFN-␥⫺/⫺ mice were infected with 500 EIU, and at day 9, mice were sacrificed and total CD4 cells were isolated for CTL assays (C).
(B) Schematic of endogenous plus TCR Tg CD4 effector generation and transfer for CTL analysis (D) and protection studies. WT or IFN-␥⫺/⫺ HNT cells are first
transferred to WT or IFN-␥⫺/⫺ mice before infection with 500 EIU. Total CD4 cells are then isolated as described at day 7 and used in CTL assays (D) or
protection studies (E). (C) Total CD4 cells from the lung were isolated as described and assayed for cytotoxicity against A20 target cells pulsed with a mixture of
class II peptides (closed symbols). Unpulsed A20 cells (open symbols) served as controls for antigen-specific killing. (D and E) Total CD4 cells were isolated from
the lungs of mice receiving TCR Tg cells and assayed for cytotoxicity against HNT-pulsed A20 target cells (D) or transferred to healthy BALB/c mice that were
then infected with 5,000 EIU PR8 and monitored for weight loss and survival (E). Shown is percent initial weight (left) and survival (right) over time from 10
individual mice. †, statistically significant difference in percent initial weight at day 9 (P ⫽ 0.002) by Student’s t test; *, P ⫽ 0.06 by log-rank test.

IFN-␥ is dispensable for CTL activity but is necessary for
complete protection from weight loss. We next asked whether
lack of IFN-␥ had any effect on generation of cytolytic activity by
CD4 T cells. We again analyzed the polyclonal response in WT and
IFN-␥⫺/⫺ mice infected with 500 EIU PR8 (Fig. 6A) and the TCR
Tg response of HNT and HNT IFN-␥⫺/⫺ CD4 cells adoptively
transferred to WT and IFN-␥⫺/⫺ mice, respectively (Fig. 6B).
Lung resident CD4 cells isolated from WT or IFN-␥⫺/⫺ mice at
day 7 to 9 after influenza virus infection express similar levels of
GrB (data not shown) and can lyse targets expressing a mixture of
HA and NP peptides (Fig. 6C, closed symbols). Similarly, total
CD4 cells isolated from the lungs of WT mice with HNT cells and
IFN-␥⫺/⫺ mice with HNT IFN-␥⫺/⫺ cells can lyse HA126-138-
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coated targets with high activity (Fig. 6D, closed symbols). Importantly, WT and IFN-␥⫺/⫺ CD4 cells possess the same level of cytolytic activity and possess approximately the same frequency of
CD4 cells reactive to influenza virus peptides.
Because WT and IFN-␥⫺/⫺ CD4 cells possessed the same relative
functional abilities, that is, promotion of antibody class switching,
ability to secrete cytokines, and lysis of target cells, we hypothesized
that WT and IFN-␥⫺/⫺ CD4 cells would be equally able to promote
survival in a lethal challenge experiment, similar to our findings obtained using in vitro-generated effectors (7). To increase the number
of influenza virus-specific CD4 cells in this system, we used the endogenous plus TCR Tg model outlined in Fig. 6B. Figure 6E (left)
demonstrates that mice given IFN-␥⫺/⫺ CD4 cells lose significantly
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FIG 7 Perforin is required for cytolytic activity by CD4 T cells in vivo and may be important for faster recovery from lethal influenza virus infection. (A) WT or

Pfn⫺/⫺ HNT cells were adoptively transferred to BALB/c Thy1.1 mice that were then infected with 500 EIU PR8. Total lung cells were isolated and incubated with
antibodies to CD4 and Thy1.2 to detect adoptively transferred HNT cells. (B) Relative level of GrB expressed by CD4⫹ Thy1.2⫹ WT or Pfn⫺/⫺ HNT cells after
gating on the cells shown in panel A. (C) Total CD4 cells were isolated from the lung using anti-CD4-conjugated magnetic beads and assayed for cytotoxicity
against HNT peptide-pulsed targets. Closed symbols denote effectors incubated with HNT peptide-pulsed targets, and open symbols denote effectors incubated
with HNT peptide-pulsed targets in the presence of antibodies to FasL. (D) Schematic of transfer protocol for weight loss and survival studies. WT or Pfn⫺/⫺
HNT cells were adoptively transferred to BALB/c mice that were then infected with 500 EIU PR8. At 7 days p.i., total CD4 cells were isolated from the lung and
DLN and transferred to healthy BALB/c or JhD mice that were then infected with 5,000 EIU PR8 and monitored for weight loss and survival. (E) Percent initial
weight over time for 10 BALB/c mice per group. (F) Total CD4 cells were isolated as described and transferred to JhD mice deficient in B cells. Percent initial
weight (left) and survival (right) over time are shown for 10 mice per group. *, a statistically significant difference in percent initial weight at day 9 (P ⫽ 0.002)
by Student’s t test.

more weight and are slower to recover than mice given WT CD4 cells.
Mice given IFN-␥⫺/⫺ CD4 cells appear to exhibit greater mortality
than mice given WT CD4 cells; however, this does not reach significance (P ⫽ 0.06). Taken together, these data indicate that IFN-␥ may
have a role in generation of, or protection mediated by, in vivo-generated effectors that was not apparent in our studies using in vitrogenerated effectors (7).
Perforin is required for cytolytic activity by CD4 T cells in
vivo and may be important for faster recovery from lethal influenza virus infection. CD4 cells demonstrate a variety of functional responses as a consequence of influenza virus infection. It is
becoming clear that CD4 T cells can contribute to antiviral responses using B cell- or helper-dependent mechanisms as well as B
cell-independent or direct mechanisms (7, 14, 39, 40). Since CD4
cells could express GrB and acquired cytolytic activity, we wanted
to determine whether this function was perforin mediated and
whether perforin could contribute to protection mediated by CD4
cells. To this end, HNT-specific CD4 T cell Tg mice were crossed
to perforin-deficient (Pfn⫺/⫺) mice to obtain influenza virus-specific CD4 T cells that cannot express perforin. WT or Pfn⫺/⫺ HNT
cells were adoptively transferred to healthy BALB/c mice that were
then infected with 500 EIU PR8. Figure 7 demonstrates that sim-
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ilar percentages of WT and Pfn⫺/⫺ cells migrate to the lung (Fig.
7A) and express comparable levels of GrB (Fig. 7B). Total CD4
cells were then isolated from the lung and assayed for the ability to
lyse HNT peptide-pulsed target cells. Figure 7C demonstrates that
WT HNT cells lyse HNT peptide-coated targets, while Pfn⫺/⫺
HNT cells do not. Furthermore, cytolytic activity in WT HNT cells
is not inhibited by antibody to FasL, suggesting that the main
mechanism of killing by adoptively transferred WT HNT cells is
perforin mediated.
To determine whether perforin contributes to protection mediated by CD4 T cells, WT or Pfn⫺/⫺ HNT cells were transferred
to healthy BALB/c mice that were then infected with 500 PR8. At 7
days postinfection, total CD4 cells were isolated from the DLN
and lung and transferred to BALB/c (D) or JhD (E) mice that were
then infected with a lethal dose of PR8 (depicted in Fig. 7D). As
seen in Fig. 7E, BALB/c mice given Pfn⫺/⫺ CD4 cells lose slightly
more weight than mice to which WT CD4 cells are adoptively
transferred, although this did not reach significance. We reasoned
that a clear difference in weight loss and survival may be difficult
to discern due to the fact that CD4 effectors can also provide help
for B cell responses, as we have shown previously (7, 18). Therefore, we repeated these experiments in JhD B cell-deficient mice
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on the BALB/c background. In the absence of B cells, at day 9
postinfection, the percent initial weight in JhD mice to which
Pfn⫺/⫺ cells were transferred is statistically lower than that in JhD
mice to which WT cells were transferred. Additionally, mice given
WT CD4 cells recover faster and have a slightly higher survival rate
than mice given Pfn⫺/⫺ CD4 cells, although this increased survival
does not reach statistical significance. These data support the concept that perforin-mediated cytotoxicity may play a role in protection conferred by CD4 T cells, but other CD4 effector functions
such as cytokine secretion and B cell help may obscure the contribution of cytolytic activity. Taken together, our results indicate
that CD4 effectors are multifunctional, with distinct activities in
the lung versus the secondary lymphoid organs, and suggest that a
combination of effector functions is necessary for complete protection.
DISCUSSION

We have demonstrated that in vivo-generated, influenza virusspecific CD4 effectors confer protection to a lethal, highly pathogenic dose of PR8. CD4 cells displayed multifunctional and distinct properties in the DLN compared to the lung after sublethal
infection. DLN CD4 cells maintained the ability to secrete IL-2
and proliferate upon restimulation, while lung resident CD4 cells
secreted IFN-␥ and IL-10. Lung CD4 cells, unlike DLN cells, expressed GrB, GrA, and perforin and could lyse peptide-pulsed
target cells, albeit at lower levels than CD8 cells from the same
anatomical site. Moreover, polyclonal and monoclonal populations of effector CD4 T cells from the lung exhibit substantial
influenza virus-specific perforin-mediated cytolytic activity. Protection against lethal influenza virus infection was mediated by
DLN and lung cells, and it appeared that optimum recovery from
infection required the expression of IFN-␥ and perforin. These
data indicate that influenza virus infection induces differentiation
of CD4 T cells with multiple functions which have a direct role in
protection against lethal infection. Furthermore, these data
should inform development of novel vaccine strategies that aim to
induce multifunctional CD4 T cell responses against infection.
CD4 cells as direct mediators in protection against lethal influenza virus infection. It has been shown previously that CD4 T
cell clones could confer protection against lethal H3N2 influenza
virus infection and Th1 clones were more effective than Th2
clones in mediating survival (14). We have previously published
that TCR Tg, HA-specific in vitro-generated CD4 effectors also
protected mice from lethal infection with H1N1 PR8 in a B cellindependent manner (7), suggesting a direct effect of CD4 T cells
in promoting survival. Because of the strong Th1 skewing in response to influenza virus infection, we reasoned that IFN-␥ may
be required for CD4 effector function in vivo and subsequent protection mediated by CD4⫹ T cells. However, experiments in which
IFN-␥-deficient cells were stimulated in vitro and investigated for
their ability to promote survival demonstrated that IFN-␥ was
dispensable for protection (7, 15). In the current study, we wanted
to extend our earlier findings and determine whether in vivo-generated CD4 effectors required IFN-␥ during the priming phase for
complete effector function and whether secretion of IFN-␥ was
important for protection. Not surprisingly, CD4 cells demonstrated the same level of proliferation, cytokine secretion, and
ability to help the antibody response in WT mice as in IFN-␥⫺/⫺
mice, indicating that IFN-␥ is not required in the priming phase
for helper functions. Further, IFN-␥ did not impact the ability of
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CD4 effectors to acquire cytolytic activity (Fig. 6B and C), consistent with our earlier findings with in vitro-generated effectors (7).
In the absence of IFN-␥, CD4 cells produce higher levels of IL-17,
possibly leading to pathogenic responses in lethally infected mice.
This has been shown in mouse models of collagen-induced arthritis, where IFN-␥⫺/⫺ C57BL/6 mice produce higher levels of IL-17
than their WT counterparts (10). Aberrant expression of IL-17
may lead to pathology in mice given ␥⫺/⫺ effectors in vivo, thus
leading to more weight loss and a longer time to recovery (Fig. 6E).
In a similar experimental system, CD4 memory cells generated by
activation of HA110-119 cells in vitro and transfer to BALB/c mice
provided protection from lethal challenge in an IFN-␥-dependent
manner (40). In recent work from the S. L. Swain lab, IFN-␥ production by memory CD4 cells was shown to be required for protection when CD8 and B cells were absent but was not required in
mice with the full complement of immune cells (K. McKinstry et
al., submitted for publication). These results are in contrast to
those of studies using IFN-␥⫺/⫺ CD4 T cell clones (15) and our
own work using in vitro-generated TCR Tg CD4 effectors (7), both
of which demonstrate that IFN-␥ has no effect on protection mediated by CD4 cells. Clearly, CD4 cells mediate protection against
lethal influenza virus infection using a variety of mechanisms, and
the relative contribution of IFN-␥ in CD4-mediated protection
may rely on the activation of concurrent CD8 and B cell responses
to influenza virus.
CD4 CTLs in acute and chronic viral infection. This report is
the first description of a bona fide CD4 killer cell isolated ex vivo in
response to acute influenza virus infection in immunocompetent
mice. Braciale’s group has demonstrated CTL activity in CD4 cell
clones generated in response to influenza virus (14), and our own
data indicate that Th1-polarized, in vitro-generated CD4 effectors
acquire perforin-mediated CTL activity (7, 8). CD4 CTLs have
been described extensively in human subjects, and some groups
hypothesize that differentiation to a cytolytic phenotype is the
result of chronic infection or antigen stimulation (2, 44) and that
the phenotype represents a CD4 effector cell at the latest stages of
differentiation (1, 6, 33, 43). Here, we have demonstrated that an
acute infection induces the differentiation of CD4 CTLs that reside in the lung, have an activated phenotype, and can kill peptidepulsed targets directly ex vivo in a perforin-dependent manner.
Reports of killing by CD4 CTLs directly ex vivo have been limited
to CMV infection in human subjects (9, 44) and in mouse models
of persistent infection, such as persistent infection with lymphocytic choriomeningitis virus (17) and mouse gamma herpesvirus
68 (34, 35). In an acute infection with influenza virus, we have
demonstrated that a monoclonal population of HA-specific CD4
cells and a polyclonal population of CD4 effectors recognizing HA
and NP peptides can lyse peptide-pulsed targets via a perforindependent mechanism. While CD4 effectors clearly utilize perforin and not FasL for killing directly ex vivo, the contribution of
CD4-delivered perforin in weight loss and survival after lethal
challenge was more obscure. In these experiments, total CD4 cells
were transferred, but only the HNT-specific fraction was perforin
deficient. Nonetheless, significant differences in weight loss were
observed in mice that received perforin-deficient CD4 effectors
compared to those that received WT effectors. More work needs
to be done to further delineate the multiple mechanisms used by
CD4 cells to mediate protection.
The physiological role of cytolytic CD4 cells has thus far not
been elucidated; however, in many infections, CD4 cells have been
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shown to contribute to viral clearance (5, 22, 24, 25). Certainly,
during influenza virus infection, in vitro-generated CD4 CTLs and
memory CD4 cells have been shown to lower viral titers (7, 40;
McKinstry et al., submitted). Figure 3 demonstrates that influenza
virus-infected epithelial cells can express class II molecules, thus
serving as targets for CD4 CTLs. However, earlier reports suggest
that class II recognition on epithelial cells was not required for
influenza viral clearance by CD4 cells (42). This observation, coupled with results presented here, suggest that CD4 cells utilize
many mechanisms that are not mutually exclusive to combat viral
disease and promote survival against lethal infection. It remains to
be determined whether in vivo-generated CD4 CTLs directly contribute to viral clearance in the primary response or whether these
cells act to downregulate inflammation by killing APCs in the
lung, as has been proposed in a tumor immunity model (4).
An intriguing question is whether CD4 CTLs develop into
memory cells and what the contribution of perforin may be in this
situation. Teijaro et al. recently reported that lung resident CD4
memory cells were more effective than splenic memory cells at
reducing viral titers and promoting recovery to lethal infection
(39). This suggests that a proportion of CD4 effectors that migrate
to the lung may remain memory cells capable of CTL activity upon
restimulation. In other yet unpublished work, McKinstry et al.
demonstrated a role for CD4 memory cell-derived perforin in
driving influenza virus escape mutants in a model of lethal infection in B cell-deficient mice (McKinstry et al., submitted). The
role of CD4 CTL in the memory response has yet to be elucidated,
and whether CD4 memory cells reexpress cytolytic proteins upon
restimulation will be important for vaccine design.
Signals important for CD4 CTL differentiation. The signals
required for differentiation of CD4 CTLs have not been clearly
identified, especially in response to infection in vivo. A straightforward hypothesis posits that CD4 CTLs are a further differentiation state of the Th1 phenotype. Our data seem to support this, as
transcriptional profiles of CD4 CTLs in the lung show high levels
of T-bet expression (Fig. 4A) and low levels of Eomes, a transcription factor important in CD8 CTL differentiation. This is in contrast to a recent report that demonstrates that Eomes is required in
vivo for CD4 CTL generation; however, that study used a model of
dual costimulation through CD134 and CD137 to differentiate
CD4 CTLs for use in tumor immunotherapy (29). The role of
Eomes in driving CD4 CTLs in the response to an acute infection
such as one with influenza virus has yet to be identified. Separate
studies from our laboratory using in vitro-generated CD4 effectors
polarized to different subsets have shown that IFN-␥ or IL-12 is
not necessary for differentiation to the cytolytic phenotype and
IL-4 can inhibit generation of CD4 CTLs, suggesting that CD4
CTLs differentiate independently of Th1 or Th2 subset polarization (8). Studies are under way to determine if T-bet or Eomes is
necessary for CD4 CTL development in response to influenza virus infection or whether CD4 CTLs express unique transcription
factors that may delineate a novel CD4 T cell subset. In support of
a separate lineage for CD4 CTLs, preliminary data from our lab
indicate that not all cells expressing CD107a, a marker of degranulation, express IFN-␥. In fact, the proportion of CD107a⫹ cells
that also express IFN-␥ is much lower for CD4 cells (30%) than
the proportion of CD107a⫹ cells that express IFN-␥ in CD8 cells
(70%) (D. M. Brown et al., unpublished observation). Ongoing
work in our laboratory aims to identify the signals required for
direct differentiation to CD4 CTLs. Given the lack of CTL markers
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in effectors generated from the DLN compared to CD4 cells from
the lung, we hypothesize that a secondary signal at the site of
infection may be responsible for further CD4 CTL differentiation.
Whether this signal is inflammatory or antigen specific is a subject
of further work from our lab.
Vaccine strategies that target CD4 CTLs. The expanding body
of literature concerning the appearance of CD4 CTLs in various
viral diseases and malignancies underscores the need to develop
alternative vaccine strategies that target CD4 CTLs (as well as multifunctional CD4 cells) to the site of infection (6, 33, 37, 43). Data
from Seder’s group have shown that vaccine-induced, multifunctional CD4 cells expressing IL-2, IFN-␥, and TNF-␣ were most
effective at protection against Leishmania major infection (12).
Moreover, an adjuvant that mimicked live infection (i.e., CpG
oligonucleotide) was the best at inducing the multifunctional CD4
T cell population. Encouraging data in seasonal influenza virus
vaccine trials in the elderly suggest that the appearance of GrBpositive CD4 cells is a better correlate of protection than the antibody response (21). In addition, FluMist live attenuated vaccine
induced a population of memory CD4 cells that were important
for lowering viral titers in a mouse model of 2009 H1N1 infection
(36). These reports all highlight the need to develop effective vaccines for infections that escape the antibody response and induce
multifunctional cytokine-secreting CD4 T cells with cytotoxic
ability as well as helper activities.
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